Garcia-Higuera I, Kuang Y, Näf D, Wasik J, D'Andrea A D
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mol Cell Biol. 1999 Jul;19(7):4866-73. doi: 10.1128/MCB.19.7.4866.
Fanconi anemia (FA) is an autosomal recessive cancer susceptibility syndrome with at least eight complementation groups (A to H). Three FA genes, corresponding to complementation groups A, C, and G, have been cloned, but their cellular function remains unknown. We have previously demonstrated that the FANCA and FANCC proteins interact and form a nuclear complex in normal cells, suggesting that the proteins cooperate in a nuclear function. In this report, we demonstrate that the recently cloned FANCG/XRCC9 protein is required for binding of the FANCA and FANCC proteins. Moreover, the FANCG protein is a component of a nuclear protein complex containing FANCA and FANCC. The amino-terminal region of the FANCA protein is required for FANCG binding, FANCC binding, nuclear localization, and functional activity of the complex. Our results demonstrate that the three cloned FA proteins cooperate in a large multisubunit complex. Disruption of this complex results in the specific cellular and clinical phenotype common to most FA complementation groups.
范可尼贫血(FA)是一种常染色体隐性遗传性癌症易感性综合征,至少有八个互补组(A至H)。对应于互补组A、C和G的三个FA基因已被克隆,但它们的细胞功能仍然未知。我们先前已证明,FANCA和FANCC蛋白在正常细胞中相互作用并形成核复合物,这表明这些蛋白在核功能中协同发挥作用。在本报告中,我们证明最近克隆的FANCG/XRCC9蛋白是FANCA和FANCC蛋白结合所必需的。此外,FANCG蛋白是包含FANCA和FANCC的核蛋白复合物的一个组成部分。FANCA蛋白的氨基末端区域对于FANCG结合、FANCC结合、核定位以及复合物的功能活性是必需的。我们的结果表明,这三种已克隆的FA蛋白在一个大型多亚基复合物中协同发挥作用。该复合物的破坏会导致大多数FA互补组共有的特定细胞和临床表型。